BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Compounds That Target MKNK2

MAPK interacting serine/threonine kinase 2 · 40 compounds in BiohacksAI corpus

MKNK2 (MAPK interacting serine/threonine kinase 2) is a biological target with 40 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MKNK2 modulation for therapeutic and biohacking applications.

Most Studied Compounds for MKNK2
300+
studies
300+
studies
297+
studies
150+
studies
117+
studies
11+
studies
All 40 Compounds — Ranked by Evidence
1
Gefitinib
5.67
confidence
2
Erlotinib
5.55
confidence
3
Tofacitinib
4.65
confidence
4
Alvocidib
4.52
confidence
5
Foretinib
4.34
confidence
6
Tozasertib
4.33
confidence
7
Vandetanib
4.30
confidence
8
Ruxolitinib
4.23
confidence
9
Ceritinib
4.19
confidence
10
Doramapimod
4.06
confidence
11
Quizartinib
3.99
confidence
12
Midostaurin
3.85
confidence
13
Canertinib
3.53
confidence
14
Bms 387032
3.47
confidence
15
Tae 684
3.43
confidence
16
Fedratinib
3.40
confidence
17
Linifanib
3.33
confidence
18
Mln 8054
3.33
confidence
19
Hispidulin
3.33
confidence
20
Sp 600125
3.22
confidence
21
Lestaurtinib
3.04
confidence
22
Genkwanin
3.04
confidence
23
Defosbarasertib
2.89
confidence
24
R 406
2.83
confidence
25
Kw 2449
2.64
confidence
26
Ast 487
2.56
confidence
27
Cp 724714
2.56
confidence
28
Merestinib
2.48
confidence
300+
studies
2.20
confidence
30
Su 014813
2.20
confidence
31
Rebastinib
2.20
confidence
32
Tg100 115
2.08
confidence
33
Tomivosertib
2.08
confidence
34
Tinodasertib
1.95
confidence
35
Aigialomycin D
1.79
confidence
117+
studies
1.10
confidence
300+
studies
0.69
confidence
150+
studies
0.69
confidence
297+
studies
0.69
confidence
11+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MKNK2 (MAPK interacting serine/threonine kinase 2). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MKNK2 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.